GlassBury AI combines agentic patient matching with culturally sensitive community education to eliminate healthcare disparities. By pairing AI with expert-curated workshops, we build the trust necessary to connect underrepresented patients with life-changing clinical trials.

FDA, MRI, Neurology Innovations, NIH Corey Hubbafd FDA, MRI, Neurology Innovations, NIH Corey Hubbafd

The Prefrontal Cortex in the 21st Century: Cutting-Edge Research and Leading Figures

The prefrontal cortex (PFC), located at the forefront of the brain, is the seat of higher-order cognitive functions that distinguish humans from other species. It plays a crucial role in decision-making, working memory, cognitive control, and social behavior. Recent advancements in neuroscience have provided unprecedented insights into the PFC's intricate workings, revealing its complexity and adaptability.

Read More
FDA, NIH, Biotech & Drug Discovery, AI/ML Corey Hubbafd FDA, NIH, Biotech & Drug Discovery, AI/ML Corey Hubbafd

The Frontier of Innovation: Cleveland Clinic and the Application of Large Language Models in Drug Discovery

The Cleveland Clinic, a renowned leader in medical innovation, is at the forefront of this revolution, pioneering the use of LLMs to address critical challenges in drug discovery. This essay will explore the innovative approaches being pursued by the Cleveland Clinic in this domain, examining the potential impact of LLMs on the future of medicine.

Read More

The Unseen Risk: Navigating the Perilous Path of Clinical Trials

The relentless march of medical advancement is a beacon of hope for millions, a testament to humanity's unyielding desire to conquer disease and extend life. At the forefront of this crusade stands the clinical trial, the crucible in which experimental treatments are rigorously tested. While these trials are often hailed as pivotal steps toward groundbreaking therapies, it is imperative to acknowledge the stark and sometimes devastating reality: participation in clinical trials can carry life-threatening consequences. Beyond the statistics and scientific jargon

Read More
Zocalo Health, #FDA, NIH Corey Hubbafd Zocalo Health, #FDA, NIH Corey Hubbafd

Bridging the Gap: Understanding Digital Mental Health Tools in Everyday Healthcare

Mental health is a crucial part of our overall well-being, yet for many people, especially those in underserved communities, getting the right mental health care can be incredibly difficult. They might face numerous obstacles, like a lack of local specialists, high costs, or the stigma often associated with seeking mental health support. This is where Integrated Primary Care (IPC) settings come into play.

Read More

Remote Relief: How Virtual Support Boosts Mood and Confidence for Families Facing Dementia

Dementia is a health crisis sweeping the globe. Experts estimate that roughly 50 million people worldwide are currently living with this condition. That enormous figure is expected to nearly double to 80 million by 2030 and potentially surpass 150 million by 2050. Alarmingly, a new dementia diagnosis happens every three seconds.

Read More
HealthTech, Dementia Diagnostics, NIH Corey Hubbafd HealthTech, Dementia Diagnostics, NIH Corey Hubbafd

The Missing Link in Alzheimer’s: How a Natural Brain Element Could Be the Key to Reversing Memory Loss

For over thirty years, Bruce Yankner has been at the very forefront of Alzheimer's research. From his early days first proving the devastating toxicity of amyloid plaques in the 1990s, to his current work uncovering the brain's hidden reliance on natural lithium, his scientific journey has been nothing short of remarkable. By finally explaining the elusive missing link

Read More

Beyond the Memory Trap: Simple Blood Tests, Subcut Injections, and Smart Care Tech are Rewriting the Alzheimer’s Story

Explore the latest 2026 Alzheimer’s research updates. Discover how simple blood tests, new home-injection trials, AI healthtech, and modern caregiving strategies are transforming memory care and hospice support.

Read More

Beyond the "Black Box": Why Trust is the Ultimate Data Moat in Clinical Trial Recruitment

In the high-stakes world of clinical research, fixed machine learning models face a silent, inevitable threat: drift. As clinical practices shift, lab equipment is recalibrated, and patient populations evolve, static algorithms slowly degrade in accuracy. At Glassbury, we recognize that a "black box" approach is insufficient for the long-term challenges of Alzheimer's disease and related CNS conditions

Read More
Big Pharma, Therapuetics, FDA Compliance, NIH Corey Hubbafd Big Pharma, Therapuetics, FDA Compliance, NIH Corey Hubbafd

Tiny Bubbles, Big Breakthrough: How Exosomes Carry Alzheimer's Treatments Past the Blood–Brain Barrier

Your brain consumes roughly 20% of your body's energy, meaning it relies on a massive network of blood vessels. To protect your central nervous system from harmful chemical swings and infections, the cells lining these blood vessels fit together like microscopic puzzle pieces sealed with airtight biological glue. This tight network is the Blood–Brain Barrier.

Read More
Clinical Operations, FDA Compliance, NIH Corey Hubbafd Clinical Operations, FDA Compliance, NIH Corey Hubbafd

The Alzheimer’s Revolution: Simple Blood Tests Spotting Risk Years Before Symptoms

For decades, Alzheimer’s disease has been a silent and elusive adversary. It crawls slowly through the brain, dismantling neural connections and building up toxic protein barriers long before the first lapse in memory occurs. Traditionally, confirming a diagnosis of Alzheimer’s has been a reactive process. Patients and their families had to wait for undeniable symptoms—confusion, forgetfulness, and changes in behavior—before seeking medical confirmation. By the time these symptoms manifest, significant and often irreversible brain damage has already occurred.

Read More

"Lonely Waves" and Genetic Timers: The Latest Alzheimer’s Breakthroughs Decoded

If you opened Google Scholar or picked up the latest issues of Nature Neuroscience or The Lancet Neurology over the past few days, you would spot two huge themes: how our sleep architecture betrays early brain changes, and how combining blood tests with genetics creates an exact clock for when symptoms will start.

Read More
FDA, Medical Advancements, NIH, Health Equity Corey Hubbafd FDA, Medical Advancements, NIH, Health Equity Corey Hubbafd

The Future of Drug Research Privacy: Navigating Evolving Regulations

Drug research is a critical endeavor that pushes the boundaries of medical science, leading to the development of life-saving treatments and therapies. However, this vital process involves collecting and analyzing sensitive personal data from research participants, raising important ethical and privacy concerns. As technology advances and data collection methods become more sophisticated, the need for robust privacy regulations in drug research is more pressing than ever.

Read More

The Ripple Effect of Altruism: Why Unconditional Love Matters

In today's fast-paced, self-centered world, it's easy to get caught up in the pursuit of personal gain and happiness. We are constantly bombarded with messages promoting individual success and the accumulation of wealth and possessions. However, amidst this relentless focus on self, there's a growing recognition of the transformative power of altruism – the selfless act of caring for others without expecting anything in return. In this blog post, we will explore the profound impact of altruistic love and why it is essential for building a more compassionate and fulfilling world.

Read More
NIH, Alzheimer's Research, FDA, Big Pharma Corey Hubbafd NIH, Alzheimer's Research, FDA, Big Pharma Corey Hubbafd

The Role of Government in Fostering a Thriving Entrepreneurial Environment for Drug Research and Development

The United States government plays a pivotal role in shaping the landscape for drug research and development (R&D), fostering an environment where entrepreneurial endeavors can flourish. This blog post delves into the multifaceted ways in which the government contributes to this ecosystem, drawing insights from authoritative sources and expert opinions.

Read More
Mental Health, Algorithms, Love, NIH Corey Hubbard Mental Health, Algorithms, Love, NIH Corey Hubbard

Revolutionizing Relationships: Unlocking ChatGPT's Transformative Power in Love & Counseling!

The landscape of mental health and relationship support is undergoing a significant transformation with the rapid advancements in Artificial Intelligence (AI). Chatbots, particularly large language models (LLMs) like ChatGPT, are increasingly capable of providing therapeutic responses

Read More
Digital Innovation, NIH, Social Good Corey Hubbard Digital Innovation, NIH, Social Good Corey Hubbard

AI for Social Good: Revolutionizing Community Well-being and Navigating the Digital Frontier

In today's rapidly evolving technological landscape, Artificial Intelligence (AI) is no longer a futuristic concept but a pervasive force significantly impacting our daily lives. Beyond its common perception as merely a technological tool, AI is increasingly recognized as a powerful agent for positive societal change,

Read More